HT
ICPT

HAP Trading’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

HAP Trading’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-54,600
Closed -$4K – 1771
2022
Q4 		$4K Sell
54,600
-11,400
-17% -$161K ﹤0.01% 1292
2022
Q3 		$51K Buy
66,000
+49,800
+307% +$802K ﹤0.01% 983
2022
Q2 		$18K Sell
16,200
-13,900
-46% -$223K ﹤0.01% 1363
2022
Q1 		$110K Sell
30,100
-27,700
-48% -$434K ﹤0.01% 1018
2021
Q4 		$110K Buy
57,800
+14,200
+33% +$239K ﹤0.01% 1208
2021
Q3 		$82K Buy
43,600
+13,100
+43% +$210K ﹤0.01% 1332
2021
Q2 		$59K Buy
30,500
+20,400
+202% +$404K ﹤0.01% 1412
2021
Q1 		$17K Sell
10,100
-8,500
-46% -$237K ﹤0.01% 1523
2020
Q4 		$17K Buy
+18,600
New +$616K ﹤0.01% 1768
2020
Q1 		– Sell
-10,400
Closed -$359K – 1582
2019
Q4 		$359K Buy
+10,400
New +$931K 0.02% 366
2017
Q4 		– Sell
-20,600
Closed -$6K – 1207
2017
Q3 		$6K Buy
+20,600
New +$2.22M ﹤0.01% 828
2016
Q3 		– Sell
-26,300
Closed -$380K – 1262
2016
Q2 		$380K Buy
+26,300
New +$3.83M 0.02% 358

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

HAP Trading's ICPT Position: Q4 2019 in Review

HAP Trading sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2019, closing a stake of 37,457 shares — an estimated $3.35M sold.

HAP Trading first reported a position in ICPT in Q1 2018 and held it in 3 quarters. The position peaked at $2.49M in Q3 2019. 215 funds tracked by Wall St. Rank hold ICPT as of Q4 2019.

  • HAP Trading reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
  • HAP Trading sold 37,457 Intercept Pharmaceuticals, Inc. shares in Q4 2019, an estimated $3.35M.
  • HAP Trading first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2018 and held it in 3 quarters.
  • HAP Trading's Intercept Pharmaceuticals, Inc. position peaked at $2.49M in Q3 2019.
  • 215 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2019.

Based on HAP Trading's 13F filing for Q4 2019, filed 11 Feb 2020.